Average Co-Inventor Count = 5.48
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Labrys Biologics, Inc. (11 from 11 patents)
2. Teva Pharmaceuticals International Gmbh (7 from 54 patents)
3. Pfizer Corporation (4 from 4,455 patents)
4. Rinat Neuroscience Corporation (1 from 52 patents)
23 patents:
1. 12202910 - Antibodies specific for FLT3 and their uses
2. 11421040 - Antibodies specific for FLT3 and their uses
3. 10597448 - Methods for treating visceral pain associated with interstitial cystitis by administering antagonist antibodies directed against calcitonin gene-related peptide
4. 10329343 - Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
5. 10323085 - Methods of treating fibromyalgia
6. 9890210 - Antagonist antibodies directed against calcitonin gene-related peptide
7. 9890211 - Antagonist antibodies directed against calcitonin gene-related peptide
8. 9884907 - Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
9. 9884908 - Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
10. 9365648 - Methods of using anti-CGRP antagonist antibodies
11. 9346881 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
12. 9340614 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
13. 9328167 - Methods of treating chronic pain
14. 9328168 - Methods of using anti-CGRP antagonist antibodies
15. 9266951 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same